메뉴 건너뛰기




Volumn 10, Issue 4, 2009, Pages 235-239

Focus on headache as an adverse reaction to drugs

Author keywords

Adverse drug reaction; Classification; Headache; Migraine; Pharmacovigilance; Side effect

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMOXICILLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLONIDINE; CYCLOPHOSPHAMIDE; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOTAMINE; FAMOTIDINE; HISTAMINE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; KETOROLAC; LEFLUNOMIDE; LEVAMISOLE; METHYLXANTHINE; METRONIDAZOLE; NAPROXEN; NITRIC OXIDE DONOR; PHOSPHODIESTERASE INHIBITOR; RANITIDINE; UNINDEXED DRUG;

EID: 67650531870     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0127-1     Document Type: Review
Times cited : (22)

References (44)
  • 1
    • 50649104448 scopus 로고    scopus 로고
    • Headache: One of the most common and troublesome adverse reactions to drugs
    • Ferrari A (2006) Headache: One of the most common and troublesome adverse reactions to drugs. Curr Drug Saf 1:43-58
    • (2006) Curr Drug Saf , vol.1 , pp. 43-58
    • Ferrari, A.1
  • 2
    • 0014457089 scopus 로고
    • International drug monitoring: The role of the hospital
    • World Health Organization
    • World Health Organization (1969) International drug monitoring: The role of the hospital. Tech Rep Ser 425:5-25
    • (1969) Tech Rep Ser , vol.425 , pp. 5-25
  • 3
    • 0008653157 scopus 로고
    • Cancer treatment: WHO recommendations for grading of acute and subacute toxicity
    • World Health Organization
    • World Health Organization (1981) Cancer treatment: WHO recommendations for grading of acute and subacute toxicity. Cancer 47:207-214
    • (1981) Cancer , vol.47 , pp. 207-214
  • 4
    • 0027196529 scopus 로고
    • MEDWatch: The new FDA medical products reporting program
    • Kessler DA (1993) MEDWatch: The new FDA medical products reporting program. Clin Pharm 12:529-532
    • (1993) Clin Pharm , vol.12 , pp. 529-532
    • Kessler, D.A.1
  • 5
    • 0036517353 scopus 로고    scopus 로고
    • Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?
    • Cohen JS (2002) Do standard doses of frequently prescribed drugs cause preventable adverse effects in women? J Am Med Womens Assoc 57:105-110
    • (2002) J Am Med Womens Assoc , vol.57 , pp. 105-110
    • Cohen, J.S.1
  • 6
    • 0026440241 scopus 로고
    • Idiosyncratic drug reactions: A mechanistic evaluation of risk factors
    • Park BK, Pirmohamed M, Kitteringham NR (1992) Idiosyncratic drug reactions: A mechanistic evaluation of risk factors. Br J Clin Pharmacol 34:377-395
    • (1992) Br J Clin Pharmacol , vol.34 , pp. 377-395
    • Park, B.K.1    Pirmohamed, M.2    Kitteringham, N.R.3
  • 7
    • 0035996570 scopus 로고    scopus 로고
    • Mechanism of idiosyncratic drug reactions: Reactive metabolite formation, protein binding and the regulation of the immune system
    • Ju C, Uetrecht JP (2002) Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. Curr Drug Metab 3:367-377
    • (2002) Curr Drug Metab , vol.3 , pp. 367-377
    • Ju, C.1    Uetrecht, J.P.2
  • 8
    • 2442433545 scopus 로고    scopus 로고
    • Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting
    • Nebeker JR, Barach P, Samore MH (2004) Clarifying adverse drug events: A clinician's guide to terminology, documentation, and reporting. Ann Intern Med 140:795-801
    • (2004) Ann Intern Med , vol.140 , pp. 795-801
    • Nebeker, J.R.1    Barach, P.2    Samore, M.H.3
  • 9
    • 33746861906 scopus 로고    scopus 로고
    • Pharmacovigilance during the pre-approval phases: An evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines
    • Hartford CG, Petchel KS, Mickail H et al (2006) Pharmacovigilance during the pre-approval phases: An evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Saf 29:657-673
    • (2006) Drug Saf , vol.29 , pp. 657-673
    • Hartford, C.G.1    Petchel, K.S.2    Mickail, H.3
  • 10
    • 0032903316 scopus 로고    scopus 로고
    • Problems assessing non-serious adverse drug reactions: Antidepressant drug therapy and sexual dysfunction
    • Michels KB (1999) Problems assessing non-serious adverse drug reactions: antidepressant drug therapy and sexual dysfunction. Pharmacotherapy 19:424-429
    • (1999) Pharmacotherapy , vol.19 , pp. 424-429
    • Michels, K.B.1
  • 11
    • 0035651985 scopus 로고    scopus 로고
    • Prescription-event monitoring and reporting of adverse drug reactions
    • Heeley E, Riley J, Layton D et al (2001) Prescription-event monitoring and reporting of adverse drug reactions. Lancet 358:1872-1873
    • (2001) Lancet , vol.358 , pp. 1872-1873
    • Heeley, E.1    Riley, J.2    Layton, D.3
  • 12
    • 0036195685 scopus 로고    scopus 로고
    • Improving safety reporting from randomised trials
    • Ioannidis JPA, Lau J (2002) Improving safety reporting from randomised trials. Drug Saf 25:77-84
    • (2002) Drug Saf , vol.25 , pp. 77-84
    • Ioannidis, J.P.A.1    Lau, J.2
  • 13
    • 0035946763 scopus 로고    scopus 로고
    • Safety reporting in clinical trials
    • Neidig JL, Koletar SL (2001) Safety reporting in clinical trials. J Am Med Assoc 285:2077-2078
    • (2001) J Am Med Assoc , vol.285 , pp. 2077-2078
    • Neidig, J.L.1    Koletar, S.L.2
  • 14
    • 0034649061 scopus 로고    scopus 로고
    • Epidemiological assessment of drug-induced disease
    • Kaufman DW, Shapiro S (2002) Epidemiological assessment of drug-induced disease. Lancet 356:1339-1343
    • (2002) Lancet , vol.356 , pp. 1339-1343
    • Kaufman, D.W.1    Shapiro, S.2
  • 15
    • 33646744337 scopus 로고    scopus 로고
    • Under-reporting of adverse drug reactions: A systematic review
    • Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions: A systematic review. Drug Saf 29:385-396
    • (2006) Drug Saf , vol.29 , pp. 385-396
    • Hazell, L.1    Shakir, S.A.2
  • 16
    • 0030111227 scopus 로고    scopus 로고
    • Methods for monitoring and documenting adverse drug reactions
    • Venulet J, ten Ham M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34:112-129
    • (1996) Int J Clin Pharmacol Ther , vol.34 , pp. 112-129
    • Venulet, J.1    ten Ham, M.2
  • 17
    • 33646057869 scopus 로고    scopus 로고
    • Headache Classification Subcommittee of the International Headache Society 2nd edn. Cephalalgia
    • Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24(Suppl 1):1-160
    • (2004) The International Classification of Headache Disorders , vol.24 , Issue.SUPPL. 1 , pp. 1-160
  • 18
    • 31344471005 scopus 로고    scopus 로고
    • Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects
    • Rief W, Avorn J, Barsky AJ (2006) Medication-attributed adverse effects in placebo groups: Implications for assessment of adverse effects. Arch Intern Med 166:155-160
    • (2006) Arch Intern Med , vol.166 , pp. 155-160
    • Rief, W.1    Avorn, J.2    Barsky, A.J.3
  • 19
    • 58849162823 scopus 로고    scopus 로고
    • The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis
    • Hazard E, Munakata J, Bigal ME et al (2009) The burden of migraine in the United States: Current and emerging perspectives on disease management and economic analysis. Value Health 12:55-64
    • (2009) Value Health , vol.12 , pp. 55-64
    • Hazard, E.1    Munakata, J.2    Bigal, M.E.3
  • 20
    • 43749091268 scopus 로고    scopus 로고
    • Adverse drug reaction reporting by patients in the Netherlands: Three years of experience
    • De Langen J, van Hunsel F, Passier A et al (2008) Adverse drug reaction reporting by patients in the Netherlands: Three years of experience. Drug Saf 31:515-524
    • (2008) Drug Saf , vol.31 , pp. 515-524
    • De Langen, J.1    van Hunsel, F.2    Passier, A.3
  • 21
    • 56349153303 scopus 로고    scopus 로고
    • Net efficacy adjusted for risk (NEAR): A simple procedure for measuring risk: Benefit balance
    • doi: 10.1371/journal.pone.0003580
    • Boada JN, Boada C, García-Sáiz M et al (2008) Net efficacy adjusted for risk (NEAR): A simplB procedure for measuring risk: benefit balance. PLoS ONE. doi: 10.1371/journal.pone.0003580
    • (2008) PLoS ONE
    • Boada, J.N.1    Boada, C.2    García-Sáiz, M.3
  • 22
    • 0032856372 scopus 로고    scopus 로고
    • Adverse drug reactions and polypharmacy in the elderly in general practice
    • Veehof LJ, Stewart RE, Meyboom-de Jong B et al (1999) Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 55:533-536
    • (1999) Eur J Clin Pharmacol , vol.55 , pp. 533-536
    • Veehof, L.J.1    Stewart, R.E.2    Meyboom-de Jong, B.3
  • 23
    • 40749114043 scopus 로고    scopus 로고
    • Epidemiology and comorbidity of headache
    • Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7:354-361
    • (2008) Lancet Neurol , vol.7 , pp. 354-361
    • Jensen, R.1    Stovner, L.J.2
  • 24
    • 53249086098 scopus 로고    scopus 로고
    • Women encounter ADRs more often than do men
    • Zopf Y, Rabe C, Neubert A et al (2008) Women encounter ADRs more often than do men. Eur J Clin Pharmacol 64:999-1004
    • (2008) Eur J Clin Pharmacol , vol.64 , pp. 999-1004
    • Zopf, Y.1    Rabe, C.2    Neubert, A.3
  • 25
    • 33846243801 scopus 로고    scopus 로고
    • Similarities and differences between chronic migraine and episodic migraine
    • Ferrari A, Leone S, Vergoni AV et al (2007) Similarities and differences between chronic migraine and episodic migraine. Headache 47:65-72
    • (2007) Headache , vol.47 , pp. 65-72
    • Ferrari, A.1    Leone, S.2    Vergoni, A.V.3
  • 26
    • 43749087335 scopus 로고    scopus 로고
    • Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: A prospective study of 1756 patients
    • Franceschi M, Scarcelli C, Niro V et al (2008) Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: A prospective study of 1756 patients. Drug Saf 31:545-556
    • (2008) Drug Saf , vol.31 , pp. 545-556
    • Franceschi, M.1    Scarcelli, C.2    Niro, V.3
  • 27
    • 0034619028 scopus 로고    scopus 로고
    • Adverse drug reactions: Definitions, diagnosis, and management
    • Edwards IR, Aronson JK (2000) Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356:1255-1259
    • (2000) Lancet , vol.356 , pp. 1255-1259
    • Edwards, I.R.1    Aronson, J.K.2
  • 28
    • 0032899232 scopus 로고    scopus 로고
    • Counting the costs of drug-related adverse events
    • White TJ, Arakelian A, Rho JP (1999) Counting the costs of drug-related adverse events. Pharmacoeconomics 15:445-458
    • (1999) Pharmacoeconomics , vol.15 , pp. 445-458
    • White, T.J.1    Arakelian, A.2    Rho, J.P.3
  • 29
    • 0028043398 scopus 로고
    • Nitroglycerin-induced headache is not dependent on histamine release: Support for a direct nociceptive action of nitric oxide
    • Iversen HK, Olesen J (1994) Nitroglycerin-induced headache is not dependent on histamine release: Support for a direct nociceptive action of nitric oxide. Cephalalgia 14:437-442
    • (1994) Cephalalgia , vol.14 , pp. 437-442
    • Iversen, H.K.1    Olesen, J.2
  • 30
    • 0034919999 scopus 로고    scopus 로고
    • Drug-related adverse events: A readers' guide to assessing literature reviews and meta-analyses
    • Ross SD (2001) Drug-related adverse events: A readers' guide to assessing literature reviews and meta-analyses. Arch Intern Med 161:1041-1046
    • (2001) Arch Intern Med , vol.161 , pp. 1041-1046
    • Ross, S.D.1
  • 32
    • 33746101875 scopus 로고    scopus 로고
    • Dipyridamole may induce migraine in patients with migraine without aura
    • Kruuse C, Lassen LH, Iversen HK et al (2006) Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26:925-933
    • (2006) Cephalalgia , vol.26 , pp. 925-933
    • Kruuse, C.1    Lassen, L.H.2    Iversen, H.K.3
  • 33
    • 0028118203 scopus 로고
    • A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks
    • Thomsen LL, Kruuse C, Iversen HK et al (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1:73-80
    • (1994) Eur J Neurol , vol.1 , pp. 73-80
    • Thomsen, L.L.1    Kruuse, C.2    Iversen, H.K.3
  • 34
    • 5444243613 scopus 로고    scopus 로고
    • Phosphodiesterase-5 inhibitors and migraine
    • Evans RW, Kruuse C (2004) Phosphodiesterase-5 inhibitors and migraine. Headache 44:925-926
    • (2004) Headache , vol.44 , pp. 925-926
    • Evans, R.W.1    Kruuse, C.2
  • 35
    • 22644446283 scopus 로고    scopus 로고
    • Migraines linked to interferon-beta treatment of multiple sclerosis
    • Khromov A, Segal M, Nissinoff J et al (2005) Migraines linked to interferon-beta treatment of multiple sclerosis. Am J Phys Med Rehabil 84:644-647
    • (2005) Am J Phys Med Rehabil , vol.84 , pp. 644-647
    • Khromov, A.1    Segal, M.2    Nissinoff, J.3
  • 36
    • 0036880354 scopus 로고    scopus 로고
    • Migraine-type headaches in children receiving chemotherapy and ondansetron
    • Khan RB (2002) Migraine-type headaches in children receiving chemotherapy and ondansetron. J Child Neurol 17:857-858
    • (2002) J Child Neurol , vol.17 , pp. 857-858
    • Khan, R.B.1
  • 37
    • 15344339211 scopus 로고    scopus 로고
    • Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms
    • Ferrari U, Empl M, Kim KS et al (2005) Calcineurin inhibitor-induced headache: Clinical characteristics and possible mechanisms. Headache 45:211-214
    • (2005) Headache , vol.45 , pp. 211-214
    • Ferrari, U.1    Empl, M.2    Kim, K.S.3
  • 39
    • 0035121924 scopus 로고    scopus 로고
    • Migraine with aura after administration of sublingual nitroglycerin tablets
    • Bank J (2001) Migraine with aura after administration of sublingual nitroglycerin tablets. Headache 41:84-87
    • (2001) Headache , vol.41 , pp. 84-87
    • Bank, J.1
  • 40
    • 15344350140 scopus 로고    scopus 로고
    • Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution
    • Toth CC, Burak K, Becker W (2005) Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution. Headache 45:245-246
    • (2005) Headache , vol.45 , pp. 245-246
    • Toth, C.C.1    Burak, K.2    Becker, W.3
  • 41
    • 0027265271 scopus 로고
    • Migraine with typical aura associated with fluoxetine therapy: Case report
    • Larson EW (1993) Migraine with typical aura associated with fluoxetine therapy: Case report. J Clin Psychiatry 54:235-236
    • (1993) J Clin Psychiatry , vol.54 , pp. 235-236
    • Larson, E.W.1
  • 42
    • 33750379444 scopus 로고    scopus 로고
    • Tadalafil associated with typical migraine aura without headache
    • Dinn RB, Wall M (2006) Tadalafil associated with typical migraine aura without headache. Cephalalgia 26:1344-1346
    • (2006) Cephalalgia , vol.26 , pp. 1344-1346
    • Dinn, R.B.1    Wall, M.2
  • 43
    • 0014360365 scopus 로고
    • Nitrolglycerin as a provocative agent in cluster headache
    • Ekbom K (1968) Nitrolglycerin as a provocative agent in cluster headache. Arch Neurol 19:487-493
    • (1968) Arch Neurol , vol.19 , pp. 487-493
    • Ekbom, K.1
  • 44
    • 33645099900 scopus 로고    scopus 로고
    • Sildenafil can trigger cluster headaches
    • Evans RW (2006) Sildenafil can trigger cluster headaches. Headache 46:173-174
    • (2006) Headache , vol.46 , pp. 173-174
    • Evans, R.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.